Atlas Trials

Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig

Clinical trial NCT07636863 · COMPLETED

Trial details

NCT number
NCT07636863
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Cancer
Start date
2025-08-21
Primary completion
2025-12-22
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.